Glypican-3 vaccine as an adjuvant therapy for hepatocellular carcinoma patients can prolong their overall survival

被引：0
|
作者：
Taniguchi, Masatake [1 ]
Sawada, Yu [2 ]
Yoshikawa, Toshiaki [2 ]
Mizuno, Shoichi [2 ]
Nakatsura, Tetsuya [1 ]
机构：
[1] Kumamoto Univ, Grad Sch, Dept Med Oncol & Translat Res, Div Canc Immunotherapy,Natl Canc Ctr, Kumamoto, Japan
[2] Kumamoto Univ, Natl Canc Ctr, Div Canc Immunotherapy, Kumamoto, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3205
引用
收藏
页码：1333 / 1333
页数：1
相关论文
共 50 条
  • [41] Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma
    Guo, Meng
    Zhang, Hailing
    Zheng, Jianming
    Liu, Yangfang
    JOURNAL OF CANCER, 2020, 11 (08): : 2008 - 2021
  • [42] Evaluation of the Glypican-3 Promoter for Transcriptional Targeting of Hepatocellular Carcinoma
    Dhungel, Bijay
    Jayachandran, Aparna
    Shrestha, Ritu
    Ramlogan-Steel, Charmaine
    Layton, Christopher J.
    Steel, Jason C.
    MOLECULAR THERAPY, 2017, 25 (05) : 68 - 68
  • [43] Identification of nanobodies against hepatocellular carcinoma marker glypican-3
    Wang, Wenyi
    Xu, Chang
    Wang, Huanan
    Jiang, Changan
    MOLECULAR IMMUNOLOGY, 2021, 131 : 13 - 22
  • [44] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
    Yukihiro Haruyama
    Hiroaki Kataoka
    World Journal of Gastroenterology, 2016, (01) : 275 - 283
  • [45] The Effect of the Etiology of Cirrhosis on Glypican-3 Expression in Hepatocellular Carcinoma
    Orrock, J. M.
    Mounajjed, T.
    Zhang, L.
    Wu, T-T
    LABORATORY INVESTIGATION, 2012, 92 : 421A - 421A
  • [46] The Effect of the Etiology of Cirrhosis on Glypican-3 Expression in Hepatocellular Carcinoma
    Orrock, J. M.
    Mounajjed, T.
    Zhang, L.
    Wu, T-T
    MODERN PATHOLOGY, 2012, 25 : 421A - 421A
  • [47] Up-regulation of Glypican-3 in Human Hepatocellular Carcinoma
    Suzuki, Masahiro
    Sugimoto, Kazushi
    Tanaka, Junichiro
    Tameda, Masahiko
    Inagaki, Yuji
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Beppu, Tetsuya
    Yoneda, Kentaro
    Yamamoto, Norihiko
    Ito, Masaaki
    Yoneda, Misao
    Uchida, Kazuhiko
    Takase, Koujiro
    Shiraki, Katsuya
    ANTICANCER RESEARCH, 2010, 30 (12) : 5055 - 5061
  • [48] Glypican-3 as a Potential Therapeutic Target for Hepatocellular Carcinoma Immunotherapy
    Trinh, Thu
    Liu, Chen
    FASEB JOURNAL, 2012, 26
  • [49] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
    Haruyama, Yukihiro
    Kataoka, Hiroaki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (01) : 275 - 283
  • [50] Glypican-3 is a potential tumor marker for hepatocellular carcinoma.
    Kleeff, JH
    Zhu, ZW
    Wang, L
    Zimmermann, A
    Korc, M
    Friess, H
    Buchler, MW
    GASTROENTEROLOGY, 2000, 118 (04) : A261 - A261
12345